a problem and a solution: aortic regurgitation and the trilogy tavi valve - pcr london valves 2023
Published 8 months ago • 2.6K plays • Length 46:59Download video MP4
Download video MP3
Similar videos
-
46:06
is only fixing functional mr in heart failure patients enough? pcr london valves 2023
-
1:01:10
tavi and beyond: tackling coronary challenges - pcr london valves 2023
-
1:28:52
remaining unmet needs and strategies in tavi - pcr london valves 2022
-
45:34
lifetime management of patients with severe aortic stenosis - pcr london valves 2021
-
58:24
best contemporary clinical practice for tavi - pcr london valves 2023
-
3:24
highlights from pcr london valves 2023 - focus on aortic valves
-
6:21
who are eligible patients for transcatheter mitral valve replacement? - pcr london valves 2023
-
5:46
prevention of stroke in transcatheter aortic valve replacement (tavr)
-
41:57
clinical update and best practices for optimal large bore management with the manta closure device
-
56:53
tavi unleashed: optimisation of immediate and long-term outcomes - pcr london valves 2023
-
57:26
an intrepid solution for transfemoral treatment of mitral regurgitation - pcr london valves 2023
-
44:53
maintaining selective coronary access after tavi and re-do tavi procedures - pcr london valves 2022
-
5:45
the science behind a valve designed for life - pcr london valves 2021
-
1:04:37
essentials of lifetime management of #tavi patients - pcr london valves 2023
-
59:51
essentials of lifetime management of tavi patients - pcr london valves 2023
-
59:28
vitaflow - the electrically enable self-expanding tavi valve - pcr london valves 2023
-
17:04
tavi valve and implantation technique: the secrets for optimising outcomes - pcr london valves 2021
-
5:10
the unmet need in severe aortic regurgitation: are we ready for tavi?
-
59:44
edwards' transcatheter trilogy: an exclusive portfolio of 3 options to treat tr - pcr london valves
-
6:15
duravr as a potential valve of choice for future valve-in-valve procedures - pcr london valves 2023
-
4:41
perspectives from the reprise iii randomised trial - pcr london valves 2017